ATP Life Science Ventures, L.P.

Insider Reports History

Entity
Company
Location
230 Park Avenue, Suite 2800, New York, NY
Signature
/s/ Seth L. Harrison, for ATP Life Science Ventures, L.P., By: Seth L. Harrison, as director of ATP III GP, Ltd., its general partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ATP Life Science Ventures, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akero Therapeutics, Inc. 10%+ Owner Common Stock 0 $0.62 Jun 28, 2021 Direct
Stoke Therapeutics, Inc. 10%+ Owner Common Stock 0 $5.74 Jun 28, 2021 Direct

Insider Reports Filed by ATP Life Science Ventures, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STOK Stoke Therapeutics, Inc. Jun 28, 2021 1 $0 4 Jun 30, 2021 10%+ Owner
AKRO Akero Therapeutics, Inc. Jun 28, 2021 1 $0 4 Jun 30, 2021 10%+ Owner